Found 17 matching trials
Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD) PHASE4 The purpose of this study was to generate additional safety and effectivene...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
BEOVU Versus Eylea in the Treatment of Diabetic Macular Edema PHASE3 Diabetic macular edema degeneration occur is a vision threatening condition...
Show More Learn More & Join Trial
Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy PHASE3 This study is a 60-week, two-arm, randomized, open-label, active-controlled...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Real-world Evaluation of Brolucizumab for the Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (Komodo Health) N/A This study was a retrospective cohort study of patients to assess the early...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Beovu Experience UZ Leuven N/A Reporting early real-world clinical data of consecutive patients on the use...
Show More Learn More & Join Trial
Prospective triAl of Modified Treat-and-extend Regimens With BroLucizumab in pachychOroid Neovasculopathy PHASE3 PNV is a recently described clinical entity; therefore, studies about treat...
Show More Location
Multiple Locations
Learn More & Join Trial
Treatment of Recalcitrant Neovascular AMD Using Brolocizumab With Immediate T&E PHASE4 The investigator propose to conduct a randomized clinical trial, investigat...
Show More Location
Grantham Hospital
Learn More & Join Trial
Special Drug Use Observational Study With Beovu Kit for Intravitreal Injection N/A This was a primary data collection-based observational special drug-use sur...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
A 52-weeks Observational Study to Evaluate the Safety of Brolucizumab in Patients With nAMD N/A This study was a prospective, uncontrolled, central registration system, mu...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Real-world Evaluation of Brolucizumab for the Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (IRIS Study) N/A This study was a retrospective cohort study of patients to assess the early...
Show More Location
Novartis Pharmaceuticals
Learn More & Join Trial